Atrikan 250 (Atrican 250)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceTenonitrosolTenonitrosol
Similar drugsTo uncover
  • Atrikan 250
    capsules inwards 
    Laboratory Innotech International     France
    • Dosage form: & nbspenteric-coated capsules
    Composition:

    Per 1 capsule

    Active substance:

    Tenonitrosol................ 250.0 mg

    Excipients:

    Peanut butter.............. 194.0 mg

    Soybean bean oil hydrogenated. 6.0 mg

    Soy lecithin........... 5.0 mg

    Capsule shell composition:

    Gelatin......................... 134.0 mg

    Sorbitol and sorbitan solution ... 66.0 mg

    Titanium dioxide (E171) 1.5 mg

    Iron colorant oxide yellow (E 172).............. 1.0 mg

    Glycerol........................ 3.5 mg

    Hypromellose phthalate 30.0 mg

    Dibutyl phthalate............. 5.2 mg

    Description:Soft oval capsules from yellow to yellow-brown, containing an oily homogeneous gray-brown mass with a weak characteristic odor.
    Pharmacotherapeutic group:Antiprotozoal agent
    ATX: & nbsp

    P.01.A.X.08   Tenonitrosol

    Pharmacodynamics:

    Anti-protozoal, active against trichomonads.

    It also has an anti-alcohol (disulfiram-like) action.

    Pharmacokinetics:Well absorbed in the gastrointestinal tract. Slowly withdrawn, which allows you to maintain the blood trichomonocidal concentration for many hours.
    Indications:Trichomoniasis of the genitourinary system.
    Contraindications:

    Hypersensitivity to tenonitrosol and other components of the drug, acute and chronic hepatic insufficiency, children's age.

    Pregnancy and lactation:

    The use of the drug during pregnancy is possible if the intended benefit to the mother exceeds the potential risk to the fetus. The drug is excreted in breast milk, so if necessary, the drug during lactation should stop breastfeeding.

    Dosing and Administration:

    For oral administration.

    One capsule 2 times a day (morning and evening) with meals for 4 days. Do not exceed the indicated daily dose.

    If you miss one or more doses, resume taking the drug at the usual dose.

    Side effects:

    From the gastrointestinal tract sometimes: nausea, a feeling of heaviness in the epigastrium, loss of appetite. Allergic reactions: urticaria, skin rashes, itching.

    If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, tell your doctor.
    Overdose:No data.
    Interaction:

    Incompatible with medications containing ethanol.

    Special instructions:

    During treatment avoid the use of alcohol and medicines containing ethanol.There is a certain risk in patients who abuse alcohol, especially when the recommended dosage is exceeded. Do not administer to people who do not able to refrain from drinking alcohol at the time of treatment.

    It is necessary to conduct simultaneous treatment of sexual partners.

    Do not wear contact lenses during treatment. eye fluid).

    Perhaps, staining the sclera and urine in yellow.

    In the case of a change in the number of blood leukocytes on the background of taking other medicinal products medications, consult a doctor.

    The drug is used to treat trichomoniasis only in adults.

    During the course of treatment of trichomoniasis, sexual intercourse should be avoided.

    Effect on the ability to drive transp. cf. and fur:There is no evidence of a negative effect of the drug on the ability to drive vehicles and other mechanisms.
    Form release / dosage:

    Capsules intestine soluble 250 mg.

    Packaging:

    8 capsules in PVC / aluminum blister.

    1 blister with instructions for use in a cardboard bundle.

    Storage conditions:

    Store at a temperature not exceeding 25 ° C.

    Keep out of the reach of children.
    Shelf life:3 years.Do not use after the expiration date printed on the package.
    Terms of leave from pharmacies:On prescription
    Registration number:P N014806 / 01
    Date of registration:29.07.2011 / 03.12.2015
    Expiration Date:Unlimited
    The owner of the registration certificate:Laboratory Innotech InternationalLaboratory Innotech International France
    Manufacturer: & nbsp
    Representation: & nbspLaboratory Innotech International Laboratory Innotech International France
    Information update date: & nbsp20.09.2017
    Illustrated instructions
      Instructions
      Up
      talkdrugs

      +8 (800)555-35-35

      [email protected]

      The reference book of medicines of the Publishing Group "GEOTAR-Media" - the leader in the field of professional medical and pharmaceutical literature.

      The information on the preparations placed on the site is intended only for specialists. Drug descriptions can not be used by patients to make an independent decision on their use.

      It is forbidden to copy any instructions of medicinal products, biologically active additives or other information from the site www.talkdrugs.info without the written permission of the Publishing House "GEOTAR".

      All rights reserved.© Publishing group "GEOTAR-Media" 2008-2016.